Protecting the hedgerow: p53 and hedgehog pathway interactions

Cell Cycle

Volumn 9, Issue 3, 2010, Pages 506-511

  Ho, Louisa ^a   Alman, Benjamin ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cancer; Gli; Hedgehog; p53; Stem cel

Indexed keywords

PROTEIN P53; SONIC HEDGEHOG PROTEIN;

BRAIN TISSUE; CANCER GROWTH; CANCER INCIDENCE; CANCER STEM CELL; CARCINOGENESIS; CARTILAGE; CELL CYCLE PROGRESSION; CELL FUNCTION; CELL POPULATION; CELL SURVIVAL; ECOSYSTEM; ENVIRONMENT; ENZYME ACTIVATION; HEDGEHOG; HEDGEROW INTERCROPPING; METASTASIS; NONHUMAN; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SKIN CULTURE; TISSUE TYPES; TUMOR VOLUME; ANIMAL; HUMAN; METABOLISM; MOLECULAR EVOLUTION; NEOPLASM; PROTEIN BINDING;

ERINACEIDAE; ERINACEINAE; MAMMALIA;

ANIMALS; EVOLUTION, MOLECULAR; HEDGEHOG PROTEINS; HUMANS; NEOPLASMS; PROTEIN BINDING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77951935186     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.3.10552     Document Type: Review

References (72)

1. Ohlmeyer JT, Kalderon D. Hedgehog stimulates maturation of Cubitus interruptus into a labile transcriptional activator. Nature 1998; 396:749-53.
2. Zhang Q, Zhang L, Wang B, Ou CY, Chien CT, Jiang J. A hedgehog-induced BTB protein modulates hedgehog signaling by degrading Ci/Gli transcription factor. Dev Cell 2006; 10:719-29. (Pubitemid 43779117)
3. Kogerman P, Grimm T, Kogerman L, Krause D, Unden AB, Sandstedt B, et al. Mammalian suppressor-of-fused modulates nuclear-cytoplasmic shuttling of Gli-1. Nat Cell Biol 1999; 1:312-9. (Pubitemid 129495783)
4. Cheng SY, Bishop JM. Suppressor of Fused represses Gli-mediated transcription by recruiting the SAP18-mSin3 corepressor complex. Proc Natl Acad Sci USA 2002; 99:5442-7.
5. Haycraft CJ, Banizs B, Aydin-Son Y, Zhang Q, Michaud EJ, et al. Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genet 2005; 1:53.
6. Huangfu D, Anderson KV. Cilia and Hedgehog responsiveness in the mouse. Proc Natl Acad Sci USA 2005; 102:11325-30.
7. Liu A, Wang B, Niswander LA. Mouse intraflagellar transport proteins regulate both the activator and repressor functions of Gli transcription factors. Development 2005; 132:3103-11. (Pubitemid 41086743)
8. Cheung HO, Zhang X, Ribeiro A, Mo R, Makino S, Puviindran V, et al. The kinesin protein Kif7 is a critical regulator of Gli transcription factors in mammalian hedgehog signaling. Sci Signal 2009; 2:29.
9. Liem KF Jr, He M, Ocbina PJ, Anderson KV. Mouse Kif7/Costal2 is a cilia-associated protein that regulates Sonic hedgehog signaling. Proc Natl Acad Sci USA 2009; 106:13377-82.
10. Endoh-Yamagami S, Evangelista M, Wilson D, Wen X, Theunissen JW, Phamluong K, et al. The mammalian Cos2 homolog Kif7 plays an essential role in modulating Hh signal transduction during development. Curr Biol 2009; 19:1320-6.
11. Wilson CW, Nguyen CT, Chen MH, Yang JH, Gacayan R, Huang J, et al. Fused has evolved divergent roles in vertebrate Hedgehog signalling and motile ciliogenesis. Nature 2009; 459:98-102.
12. Rohatgi R, Milenkovic L, Scott MP. Patched1 regulates hedgehog signaling at the primary cilium. Science 2007; 317:372-6. (Pubitemid 47106377)
13. Kovacs JJ, Whalen EJ, Liu R, Xiao K, Kim J, Chen M, et al. Beta-arrestin-mediated localization of smoothened to the primary cilium. Science 2008; 320:1777-81. (Pubitemid 351931292)
14. Berbari NF, O'Connor AK, Haycraft CJ, Yoder BK. The primary cilium as a complex signaling center. Curr Biol 2009; 19:526-35.
15. Goodrich LV, Milenkovic L, Higgins KM, Scott MP. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997; 277:1109-13. (Pubitemid 27371635)
16. Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, et al. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 2002; 297:1559-61.
17. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996; 85:841-51. (Pubitemid 26192135)
18. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996; 272:1668-71. (Pubitemid 26200029)
19. Kappler R, Bauer R, Calzada-Wack J, Rosemann M, Hemmerlein B, Hahn H. Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma. Oncogene 2004; 23:8785-95. (Pubitemid 39593293)
20. Wong SY, Seol AD, So PL, Ermilov AN, Bichakjian CK, Epstein EH Jr, et al. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med 2009; 15:1055-61.
21. Jiang J, Hui CC. Hedgehog signaling in development and cancer. Dev Cell 2008; 15:801-12.
22. Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, et al. A paracrine requirement for hedgehog signalling in cancer. Nature 2008; 455:406-10.
23. Vousden KH, Prives C. Blinded by the light: The growing complexity of p53. Cell 2009; 137:413-31.
24. Teodoro JG, Parker AE, Zhu X, Green MR. p53-mediated inhibition of angiogenesis through upregulation of a collagen prolyl hydroxylase. Science 2006; 313:968-71. (Pubitemid 44267388)
25. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006; 126:121-34. (Pubitemid 44040988)
26. Gatz SA, Wiesmuller L. p53 in recombination and repair. Cell Death Differ 2006; 13:1003-16.
27. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 2005; 18:283-93. (Pubitemid 41350534)
28. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004; 431:707-12. (Pubitemid 39382619)
29. Linke SP, Sengupta S, Khabie N, Jeffries BA, Buchhop S, Miska S, et al. p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res 2003; 63:2596-605. (Pubitemid 36313604)
30. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P, et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003; 11:577-90. (Pubitemid 36385115)
31. Allison SJ, Milner J. Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy. Cancer Res 2003; 63:6674-9. (Pubitemid 37322946)
32. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 1990; 250:1233-8. (Pubitemid 120031831)
33. Liu G, McDonnell TJ, Montes de Oca Luna R, Kapoor M, Mims B, et al. High metastatic potential in mice inheriting a targeted p53 missense mutation. Proc Natl Acad Sci USA 2000; 97:4174-9. (Pubitemid 30226106)
34. Milner J, Medcalf EA. Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 1991; 65:765-74. (Pubitemid 121001308)
35. Wolf D, Harris N, Rotter V. Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene. Cell 1984; 38:119-26. (Pubitemid 15216541)
36. Zalcenstein A, Stambolsky P, Weisz L, Muller M, Wallach D, Goncharov TM, et al. Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants. Oncogene 2003; 22:5667-76. (Pubitemid 37102703)
37. Gaiddon C, Lokshin M, Ahn J, Zhang T, Prives C. A subset of tumor-derived mutant forms of p53 downregulate p63 and p73 through a direct interaction with the p53 core domain. Mol Cell Biol 2001; 21:1874-87. (Pubitemid 32156407)
38. Flores ER, Sengupta S, Miller JB, Newman JJ, Bronson R, Crowley D, et al. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 2005; 7:363-73. (Pubitemid 40544653)
39. Midgley CA, Lane DP. p53 protein stability in tumor cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 1997; 15:1179-89.
40. Donehower LA, Lozano G. 20 years studying p53 functions in genetically engineered mice. Nat Rev Cancer 2009; 9:831-41.
41. +/- mouse model in carcinogenicity testing. Toxicol Pathol 2001; 29:147-54.
42. Brosh R, Rotter V. When mutants gain new powers: news from the mutant p53 field. Nat Rev Cancer 2009; 9:701-13.
43. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, et al. Restoration of p53 function leads to tumor regression in vivo. Nature 2007; 445:661-5. (Pubitemid 46232887)
44. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, et al. Senescence and tumor clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445:656-60. (Pubitemid 46232886)
45. Martins CP, Brown-Swigart L, Evan GI. Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 2006; 127:1323-34. (Pubitemid 44960417)
46. Ashcroft M, Taya Y, Vousden KH. Stress signals utilize multiple pathways to stabilize p53. Mol Cell Biol 2000; 20:3224-33. (Pubitemid 30215034)
47. Meletis K, Wirta V, Hede SM, Nister M, Lundeberg J, Frisen J. p53 suppresses the self-renewal of adult neural stem cells. Development 2006; 133:363-9. (Pubitemid 43210724)
48. Liu Y, Elf SE, Asai T, Miyata Y, Sashida G, Huang G, et al. The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior. Cell Cycle 2009; 8:3120-4.
49. Ma W, Sung HJ, Park JY, Matoba S, Hwang PM. A pivotal role for p53: balancing aerobic respiration and glycolysis. J Bioenerg Biomembr 2007; 39:243-6. (Pubitemid 47619376)
50. Bensaad K, Vousden KH. p53: new roles in metabolism. Trends Cell Biol 2007; 17:286-91.
51. Wetmore C, Eberhart DE, Curran T. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res 2001; 61:513-6. (Pubitemid 32128609)
52. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008; 8:743-54.
53. Lee Y, Kawagoe R, Sasai K, Li Y, Russell HR, Curran T, McKinnon PJ. Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene 2007; 26:6442-7. (Pubitemid 47494220)
54. Tiet TD, Hopyan S, Nadesan P, Gokgoz N, Poon R, Lin AC, et al. Constitutive hedgehog signaling in chondrosarcoma upregulates tumor cell proliferation. Am J Pathol 2006; 168:321-30. (Pubitemid 43062583)
55. Hopyan S, Gokgoz N, Poon R, Gensure RC, Yu C, Cole WG, et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet 2002; 30:306-10.
56. Ho L, Stojanovski A, Whetstone H, Wei QX, Mau E, Wunder JS, et al. Gli2 and p53 cooperate to regulate IGFBP-3-mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors. Cancer Cell 2009; 16:126-36.
57. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995; 377:646-9.
58. Grimberg A. p53 and IGFBP-3: apoptosis and cancer protection. Mol Genet Metab 2000; 70:85-98.
59. Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Philpott MP, et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res 2004; 64:7724-31. (Pubitemid 39446903)
60. Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM. Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene 2001; 20:240-51. (Pubitemid 32150269)
61. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432:324-31.
62. Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P, et al. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 2008; 14:238-49.
63. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009; 458:776-9.
64. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz I, Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal and tumorigenicity. Curr Biol 2007; 17:165-72. (Pubitemid 46107823)
65. Stecca B, Ruiz I, Altaba A. A GLI1-p53 inhibitory loop controls neural stem cell and tumor cell numbers. EMBO J 2009; 28:663-76.
66. Abe Y, Oda-Sato E, Tobiume K, Kawauchi K, Taya Y, Okamoto K, et al. Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Proc Natl Acad Sci USA 2008; 105:4838-43. (Pubitemid 351753833)
67. Katoh Y, Katoh M. Integrative genomic analyses on GLI2: mechanism of Hedgehog priming through basal GLI2 expression, and interaction map of stem cell signaling network with p53. Int J Oncol 2008; 33:881-6.
68. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006; 124:207-19. (Pubitemid 43069320)
69. Smeenk L, van Heeringen SJ, Koeppel M, van Driel MA, Bartels SJ, Akkers RC, et al. Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res 2008; 36:3639-54. (Pubitemid 351917528)
70. Wang B, Xiao Z, Ren EC. Redefining the p53 response element. Proc Natl Acad Sci USA 2009; 106:14373-8.
71. + cancer stem cells in patched-1-deficient mouse medulloblastoma. Cancer Res 2009; 69:4682-90.
72. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10.